Aquestive Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 4.61, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Aquestive Therapeutics Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 79 days, from 60 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 273 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 1492 to 1544.

What is Receivable Turnover Ratio?
What is Aquestive Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AQST Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	-	-	-	141.87 %	-
Y / Y Revenue Change	-40.99 %	38.15 %	65.67 %	9.67 %	-5.43 %
Receivable Turnover Ratio (TTM)	4.61	6.08	8.16	10.03	23.64
AQST's Total Ranking	# 1544	# 1492	# 888	# 2233	#
Accounts Receivable average collection period days	79	60	45	36	15
Seq. Receivable Change	-37.75 %	59.23 %	-61.34 %	-	-
Seq. Revenue Change	-45.31 %	-4.34 %	11 %	1.62 %	28.03 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 81
Healthcare Sector	# 274
Overall Market	# 1544

Receivable Turnover Ratio Statistics
High	Average	Low
31.35	15.58	6.25
(Dec 31 2024)		(Sep 30 2019)

AQST Company Profile • Back to AQST Efficiency Comparisons • Compare AQST Receivables Turnover Ratio to its Competitors

Financial Statements
Aquestive Therapeutics Inc 's Accounts Receivable	$ 7 Millions	Visit AQST's Balance sheet
Aquestive Therapeutics Inc 's Sales TTM	$ 49 Millions	Visit AQST's Income Statement
Sources of AQST's Revenues		Visit AQST's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AQST's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AQST's Growth Rates	AQST's Roa	AQST's Inventory Turnover Ratio	AQST's Dividend Comparisons
AQST's Profitability Ratios	AQST's Roi	AQST's Asset Turnover Ratio	AQST's Dividend Growth
AQST's Valuation Ratios	AQST's Roe	AQST's Financial Strength Ratios	AQST's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
U S Physical Therapy Inc	18.16	$ 837.629 Millions	$ 46.137 Millions
Alpha Pro Tech Ltd	17.54	$ 64.940 Millions	$ 3.702 Millions
Biogen Inc	15.19	$ 10,297.300 Millions	$ 677.900 Millions
Lifestance Health Group Inc	14.89	$ 1,676.889 Millions	$ 112.631 Millions
Amneal Pharmaceuticals Inc	14.24	$ 3,196.184 Millions	$ 224.488 Millions
Corcept Therapeutics Inc	13.44	$ 963.647 Millions	$ 71.710 Millions
Precipio inc	13.38	$ 27.762 Millions	$ 2.075 Millions
Chemed Corporation	12.65	$ 2,661.041 Millions	$ 210.387 Millions
Caredx Inc	11.75	$ 497.396 Millions	$ 42.330 Millions
Teladoc Health Inc	11.50	$ 2,468.143 Millions	$ 214.604 Millions
Biodesix Inc	11.45	$ 105.212 Millions	$ 9.192 Millions
Gossamer Bio Inc	11.37	$ 78.423 Millions	$ 6.896 Millions
Icu Medical Inc	11.32	$ 2,183.556 Millions	$ 192.845 Millions
Mannkind Corporation	10.97	$ 413.370 Millions	$ 37.686 Millions
Lensar Inc	10.64	$ 60.079 Millions	$ 5.645 Millions
Iqvia Holdings Inc	10.43	$ 17,311.000 Millions	$ 1,659.500 Millions
Voyager Therapeutics Inc	9.84	$ 25.108 Millions	$ 2.551 Millions
Myomo Inc	9.66	$ 47.775 Millions	$ 4.947 Millions
Encompass Health Corporation	9.41	$ 6,338.100 Millions	$ 673.625 Millions
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Co diagnostics Inc	9.12	$ 0.859 Millions	$ 0.094 Millions
Pacs Group Inc	8.88	$ 5,705.049 Millions	$ 642.729 Millions
Lexicon Pharmaceuticals Inc	8.77	$ 38.537 Millions	$ 4.396 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Avita Medical Inc	8.65	$ 84.683 Millions	$ 9.795 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions
Tenet Healthcare Corp	8.54	$ 22,154.000 Millions	$ 2,593.250 Millions
Brightspring Health Services Inc	8.50	$ 9,479.144 Millions	$ 1,114.763 Millions
Sotera Health Company	8.49	$ 1,230.250 Millions	$ 144.974 Millions

Date modified: 2026-11-04T16:54:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.